BE531437A - - Google Patents

Info

Publication number
BE531437A
BE531437A BE531437DA BE531437A BE 531437 A BE531437 A BE 531437A BE 531437D A BE531437D A BE 531437DA BE 531437 A BE531437 A BE 531437A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE531437A publication Critical patent/BE531437A/xx
Priority claimed from GB2361653A external-priority patent/GB767824A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28—Cinnolines
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02C—GAS-TURBINE PLANTS; AIR INTAKES FOR JET-PROPULSION PLANTS; CONTROLLING FUEL SUPPLY IN AIR-BREATHING JET-PROPULSION PLANTS
    • F02C7/00—Features, components parts, details or accessories, not provided for in, or of interest apart form groups F02C1/00 - F02C6/00; Air intakes for jet-propulsion plants
    • F02C7/06—Arrangements of bearings; Lubricating
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02C—GAS-TURBINE PLANTS; AIR INTAKES FOR JET-PROPULSION PLANTS; CONTROLLING FUEL SUPPLY IN AIR-BREATHING JET-PROPULSION PLANTS
    • F02C7/00—Features, components parts, details or accessories, not provided for in, or of interest apart form groups F02C1/00 - F02C6/00; Air intakes for jet-propulsion plants
    • F02C7/22—Fuel supply systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Combustion & Propulsion (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
BE531437D 1953-08-26 BE531437A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2845381X 1953-08-26
GB2361653A GB767824A (en) 1954-07-29 1954-07-29 Improvements in preparations for the treatment of the human skin

Publications (1)

Publication Number Publication Date
BE531437A true BE531437A (fr)

Family

ID=32328117

Family Applications (1)

Application Number Title Priority Date Filing Date
BE531437D BE531437A (fr) 1953-08-26

Country Status (5)

Country Link
US (1) US2845381A (fr)
BE (1) BE531437A (fr)
CH (1) CH330670A (fr)
DE (1) DE1017748B (fr)
NL (2) NL88180C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0316780A1 (fr) * 1987-11-13 1989-05-24 Luderschmidt, Christoph, Prof. Dr. med. Application de l'éthistérone pour le traitement topique de l'acné ou de l'alopézie androgénétique

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940989A (en) * 1955-06-01 1960-06-14 Syntex S A Mexico City 19-nor-17alpha ethinyl-androstan-17beta-ol-3-one
US2953582A (en) * 1956-04-23 1960-09-20 Farmaceutici Italia 4-chloro-adrenosterone
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US2939819A (en) * 1957-01-25 1960-06-07 British Drug Houses Ltd 21-alkyl-17beta-hydroxy-17alpha-pregn-20-ynes, therapeutic compositions comprising same, and process therefor
GB897986A (en) * 1957-09-03 1962-06-06 Syntex Sa New cyclopentanophenanthrene compounds and process for the production thereof
US3028401A (en) * 1957-11-27 1962-04-03 Syntex Sa 6-fluoro-19-nor-testosterone derivatives
US2936312A (en) * 1958-02-10 1960-05-10 Upjohn Co 3-oxygenated 6, 17alpha-dimethylandrostan-17beta-ols
US3088953A (en) * 1958-03-19 1963-05-07 Syntex Corp Delta4-estrene-10beta, 17beta-diol-3-one compounds and process therefor
US2937192A (en) * 1958-03-31 1960-05-17 Searle & Co 17alpha-methyl-17beta-hydroxyestran-3-one
US3070612A (en) * 1958-06-02 1962-12-25 Upjohn Co 4-alkyl compounds of the androstane series and esters thereof
DE1099129B (de) * 1958-09-10 1961-02-09 Thomae Gmbh Dr K Hautpflegemittel
US3010957A (en) * 1958-11-26 1961-11-28 Schering Corp Ethinyl androstadienes
US3060174A (en) * 1960-01-14 1962-10-23 Ciba Geigy Corp Esters of the androstane series and process for their manufacture
US3083196A (en) * 1960-02-19 1963-03-26 Merck & Co Inc 5alpha-methyl-steroid-3-ones
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base
US4496554A (en) * 1979-01-17 1985-01-29 E. R. Squibb & Sons, Inc. Oleaginous emollient vehicle for steroid formulations
US4391799A (en) * 1980-02-15 1983-07-05 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for treating white phosphorus burn wounds
US4393048A (en) * 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4778787A (en) * 1985-12-20 1988-10-18 Trustees Of Boston University Method for treatment of angina and myocardial infarctions with omental lipids
US5641768A (en) * 1989-11-17 1997-06-24 Loria; Roger M. 5-androstene 3β, 17β diol for treatment
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
US5912240A (en) * 1997-04-10 1999-06-15 Loria; Roger M. 5-androstene 3β, 17α diol as an inhibitor of tumor growth
US20060079492A1 (en) * 1999-10-25 2006-04-13 Ahlem Clarence N Compositions and treatment methods
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
PT1955700E (pt) 1999-09-30 2011-05-04 Harbor Biosciences Inc Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
AU2005301035A1 (en) * 2004-11-01 2006-05-11 Endorecherche, Inc. Use of androgens to reduce the likelihood of acquiring or to treat skin aging
GB2420281A (en) * 2004-11-22 2006-05-24 Stegram Pharmaceuticals Ltd Topical formulations for use in the treatment or prevention of dermatological conditions
EP2147674A1 (fr) * 2008-07-24 2010-01-27 Besins Healthcare Compositions pharmaceutiques transdermiques comprenant du danazol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0316780A1 (fr) * 1987-11-13 1989-05-24 Luderschmidt, Christoph, Prof. Dr. med. Application de l'éthistérone pour le traitement topique de l'acné ou de l'alopézie androgénétique

Also Published As

Publication number Publication date
NL190146A (fr)
NL88180C (fr)
US2845381A (en) 1958-07-29
DE1017748B (de) 1957-10-17
CH330670A (de) 1958-06-15

Similar Documents

Publication Publication Date Title
AT193854B (fr)
AT191364A (fr)
AT190646B (fr)
BE517130A (fr)
AT193331B (fr)
AT191026B (fr)
AT191140B (fr)
AT192380B (fr)
AT199365B (fr)
AT191238B (fr)
AT194372B (fr)
AT194824B (fr)
AT195162B (fr)
AT195400B (fr)
AT196785B (fr)
AT197771B (fr)
AT199317B (fr)
AT194074B (fr)
AT205166B (fr)
AT213751B (fr)
BE425967A (fr)
BE516823A (fr)
BE324631A (fr)
BE326981A (fr)
BE517261A (fr)